Compounds > s20098
Page last updated: 2024-08-25

s20098 and Attention Deficit and Disruptive Behavior Disorders

s20098 has been researched along with Attention Deficit and Disruptive Behavior Disorders in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Alamiri, B; Naguy, A1

Other Studies

1 other study(ies) available for s20098 and Attention Deficit and Disruptive Behavior Disorders

ArticleYear
Successful agomelatine monotherapy for an adolescent with attention deficit hyperactivity disorder and comorbid migraine.
    CNS spectrums, 2022, Volume: 27, Issue:2

    Topics: Acetamides; Adolescent; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Comorbidity; Humans; Migraine Disorders; Naphthalenes

2022